Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transplant hyperlipidaemia

R M Jindal1

  • 1Department of Surgery, Indiana University School of Medicine, Indianapolis 46202, USA.

Postgraduate Medical Journal
|March 14, 1998
PubMed
Summary
This summary is machine-generated.

Managing post-transplant hyperlipidemia with medication, diet, and exercise is crucial. Lowering lipid levels may reduce chronic transplant rejection and improve recipients

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Taking and Decision Making in Kidney Paired Donation: A Qualitative Study by Semistructured Interviews.

Transplantation proceedings·2018
Same author

Comment: Kidney Exchange to Overcome Financial Barriers to Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Kidney Paired-Donation Program Versus Global Kidney Exchange in India.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Incidence of diabetes and hypertension in indigenous Amerindian village in Guyana, South America.

Indian journal of nephrology·2016
Same author

Organ Donation After Euthanasia: A Dutch Practical Manual.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Diabetes, hypertension, sanitation, and health education by high school students in Guyana, South America.

Indian journal of nephrology·2016
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Area of Science:

  • Cardiology
  • Nephrology
  • Transplant Medicine

Background:

  • Post-transplant hyperlipidemia is a common complication following organ transplantation.
  • Elevated lipid levels can contribute to cardiovascular disease and graft dysfunction.

Purpose of the Study:

  • To highlight the importance of managing post-transplant hyperlipidemia.
  • To discuss the role of pharmacological agents, dietary modification, and exercise in lipid reduction.
  • To explore the potential impact of lipid reduction on chronic allograft rejection and patient quality of life.

Main Methods:

  • Review of current literature on post-transplant hyperlipidemia management.
  • Analysis of the relationship between hyperlipidemia, cardiovascular disease, and transplant outcomes.

Related Experiment Videos

  • Emphasis on a multi-faceted approach involving medication, lifestyle changes, and regular monitoring.

    • Main Results:

    • Judicious and timely use of pharmacological agents alongside dietary modification and exercise is recommended for hyperlipidemia correction.
    • Reduction in hyperlipidemia may play a role in decreasing the incidence of chronic allograft rejection.
    • Active intervention in managing atherosclerotic disease can lower morbidity and mortality.

    Conclusions:

    • Effective management of post-transplant hyperlipidemia is essential for improving long-term transplant outcomes.
    • Addressing lipid abnormalities can mitigate risks associated with cardiovascular disease and chronic rejection.
    • Optimizing lipid profiles contributes to a better quality of life for transplant recipients.